Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells [Research Brief]

This article is highlighted in the In This Issue feature, p. 1201

Source: Cancer Discovery - November 1, 2017 Category: Cancer & Oncology Authors: Shum, T., Omer, B., Tashiro, H., Kruse, R. L., Wagner, D. L., Parikh, K., Yi, Z., Sauer, T., Liu, D., Parihar, R., Castillo, P., Liu, H., Brenner, M. K., Metelitsa, L. S., Gottschalk, S., Rooney, C. M. Tags: Research Brief Source Type: research